Cut-off value of D-dimer in pulmonary thromboembolism and pneumonia

Aim: The differential diagnosis of pulmonary thromboembolism (PTE) and pneumonia remains difficult in emergency rooms. High D-dimer levels in the pneumonia may be misdiagnosed as PTE on the basis of similar clinical, radiological, and laboratory findings. Since D-dimer elevation may also be seen in pneumonia cases, the comparison of D-dimer values in patients diagnosed as pneumonia and PTE, in order to determine a cut-off value between the 2 diseases, was aimed in this study. Materials and methods: Patients in the community acquired pneumonia (CAP) group were classified according to the American Thoracic Society (ATS) 2001 criteria. Groups III and IV patients, who were hospitalized, were included in the study. The final CAP group consisted of 52 patients (30 in Group IIIa, 15 in Group IIIb, 2 in Group IVa, and 5 in Group IVb) and 68 patients with a diagnosis of PTE. All patients&#8217; D-dimer levels in the first day were recorded. Results: Mean D-dimer levels of the PTE and pneumonia group were 4868 ng/mL and 2068 ng/mL, respectively (P < 0.001). Cut-off value was 4374 ng/mL. Mean levels of D-dimer in the massive PTE group and sub-massive PTE group were 5438 ng/mL and 4175 ng/mL,respectively, (P = 0.04). Conclusion: Elevation of D-dimer is more significant in PTE than pneumonia. As a result, if D-dimer level is higher than 4374 ng/mL, the patient should be evaluated for the diagnosis of PTE. A cut-off value of 4374 ng/mL will help the discrimination of PTE and pneumonia.

Cut-off value of D-dimer in pulmonary thromboembolism and pneumonia

Aim: The differential diagnosis of pulmonary thromboembolism (PTE) and pneumonia remains difficult in emergency rooms. High D-dimer levels in the pneumonia may be misdiagnosed as PTE on the basis of similar clinical, radiological, and laboratory findings. Since D-dimer elevation may also be seen in pneumonia cases, the comparison of D-dimer values in patients diagnosed as pneumonia and PTE, in order to determine a cut-off value between the 2 diseases, was aimed in this study. Materials and methods: Patients in the community acquired pneumonia (CAP) group were classified according to the American Thoracic Society (ATS) 2001 criteria. Groups III and IV patients, who were hospitalized, were included in the study. The final CAP group consisted of 52 patients (30 in Group IIIa, 15 in Group IIIb, 2 in Group IVa, and 5 in Group IVb) and 68 patients with a diagnosis of PTE. All patients&#8217; D-dimer levels in the first day were recorded. Results: Mean D-dimer levels of the PTE and pneumonia group were 4868 ng/mL and 2068 ng/mL, respectively (P < 0.001). Cut-off value was 4374 ng/mL. Mean levels of D-dimer in the massive PTE group and sub-massive PTE group were 5438 ng/mL and 4175 ng/mL,respectively, (P = 0.04). Conclusion: Elevation of D-dimer is more significant in PTE than pneumonia. As a result, if D-dimer level is higher than 4374 ng/mL, the patient should be evaluated for the diagnosis of PTE. A cut-off value of 4374 ng/mL will help the discrimination of PTE and pneumonia.

___

  • Coche EE, Muller NE, Kim K, Wiggs BR, Mayo JR. Acute Pulmonary Embolism: Ancillary findings at spiral CT. Radiology 1998; 207: 753-758.
  • Castro DJ, Perez- Rodriguez E, Montaner L, Flores J, Nuevo GD. Diagnostic value of D dimer in pulmonary embolism and pneumonia. Respiration 2001; 68: 371-375.
  • Bartlett JG, Dowell SF, Mandell LA. Practice guidelines fort he management of community-acquired pneumonia at adults. Clin Infect Dis 2000; 31: 347-382.
  • Deitcher SR, Eisenberg PR. Elevated concentrations of cross- linked fibrin degradation product in plasma. Chest 1993; 103: 1107-1112.
  • Querol- Ribelles JM., Tenias JM, Grau E, Querol-Borras JM, Climent JM, Gomez E. Plasma d-dimer levels correlate with outcomes in patients with community acquired pneumonia. Chest 2004; 126: 1015-1016.
  • Espana PR, Capelastegui A, Gorordo I, Esteban C, Oribe M, Ortega M. Development and validation of a clinical prediction rule for severe community acquired pneumonia Am J Respir Crit Care Med 2006; 174: 1249-1256.
  • Shilon Y, Shitrit AB, Rudensky B, Yinnon AM, Nargalit M, Sulkes J. A rapid quantitative assay at admission correlates with the severity of community acquired pneumonia. Blood Coagul Fibrinolysis 2003; 14:745-748.
  • Grau E, Tenias JM, Soto MJ, Gutierrez MR, Lecumberri R, Perez JL. D-dimer levels correlate with mortality in patients with acute pulmonary embolism: Findings from the RIETE registry. Crit Care Med 2007; 35: 1937-1941.
  • Sasaki K, Senda M, Ishikura T, Ota H, Mori T, Tsukiyama H et al. The relationship between ambulatory ability before surgery and D-dimer value after total hip arthroplasty: The evaluation of ambulatory ability by the time “Up and Go” test. Act Med Okayama 2005; 59: 222-230.
  • Mikaeilli H, Zarghami N, Yazdchi M, Mardani M, Ansarin K. On-admission level of serum d-dimer and the severity of community-acquired pneumonia. Pak J Biol Sci 2009; 15: 514- 517.
  • Chalmers JD, Singanayagam A, Scally C, Hill AT. Admission D- dimer can identify low-risk patients with community-acquired pneumonia. Ann Emerg Med. 2009; 53: 633-638.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Handedness differences in dental traumatic injuries of boxers

Özkan MİLOĞLU, İlhan ŞEN, Recep GÜRSOY, Şenol DANE, Abubekir HARORLI, Sadettin DAĞISTAN, Binali ÇAKUR

Co-occurrence of internal carotid artery agenesis with multicystic dysplastic kidney

İpek AKIL, Muzaffer POLAT, Serdar TARHAN, Yılmaz Gülgün OVALI, Petek BAYINDIR

Does employment status influence obesity prevalence among females? A comparative study from Ankara, Turkey

Dilek ASLAN, Celile HATİPOĞLU, Zeynep ALTIN, Necmiye BEYDAĞ

Cut-off value of D-dimer in pulmonary thromboembolism and pneumonia

Asiye KANBAY, Ayşegül KARALEZLİ, Selda KAYA, Elif BABAOĞLU, S. Cibali AÇIKGÖZ, H. Canan HASANOĞLU, Derya ÖZTUNA

The effects of adding tramadol to ropivacaine on axillary brachial plexus blockade in uremic patients*

Bayazıt DİKMEN

Management of thyroid cancer associated with elevated serum thyroglobulin and negative radioiodine scanning

Management Of Thyroid Cancer Associated SCANNİNG, Sinan ÇAĞLAYAN, Muammer URHAN, Onur SILDIROĞLU, Yavuz KURT, Mehmet Emin ÖNDE, Yavuz NARİN

Hacettepe Üniversitesi erişkin hastanesi’nde izole edilen hastane enfeksiyonu etkeni metisiline dirençli Staphylococcus aureus suşlarının antimikrobiyallere duyarlılık, indüklenebilir makrolid-linkozamid-streptogramin B direnç ve klonal benzerlik durumları

Gökhan METAN, Belgin ALTUN, Serhat ÜNAL, Pınar ZARAKOĞLU, Gülşen HASÇELİK

Anormal parmakla rektal muayene klinik lokalize prostat kanserli hastalarda yüksek radikal prostatektomi Gleason skorunu (≥7) öngörmede bağımsız bir parametredir

Cüneyt ÖZDEN, Mesut ÇETİNKAYA, Ali MEMİŞ, Özgür UĞURLU, Mehmet YARIŞ, Ç. Volkan ÖZTEKİN, A. Özgür AKDEMİR

Anti-HAV seroprevalence in Turkish military personnel and its relation with demographic properties

İsmail Yaşar AVCI, Çakır GÜNEY, CAN Polat EYİGÜN, Hanefi Cem GÜL, Yakup Hakan BAŞARAN, Bülent A. BEŞİRBELLİOĞLU, Ömer COŞKUN, Alaaddin PAHSA, Recai OĞUR, Cengiz Han AÇIKEL

Management of thyroid cancer associated with elevated serum thyroglobulin and negative radioiodine

Yavuz KURT, Mehmet Emin ÖNDE, Muammer URHAN, Yavuz NARİN, Onur SILDIROĞLU, Sinan ÇAĞLAYAN